Ole Schmitz

5.3k total citations
57 papers, 3.6k citations indexed

About

Ole Schmitz is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Ole Schmitz has authored 57 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 31 papers in Molecular Biology and 22 papers in Surgery. Recurrent topics in Ole Schmitz's work include Metabolism, Diabetes, and Cancer (26 papers), Pancreatic function and diabetes (22 papers) and Diabetes Treatment and Management (19 papers). Ole Schmitz is often cited by papers focused on Metabolism, Diabetes, and Cancer (26 papers), Pancreatic function and diabetes (22 papers) and Diabetes Treatment and Management (19 papers). Ole Schmitz collaborates with scholars based in Denmark, United States and United Kingdom. Ole Schmitz's co-authors include Birgitte Brock, Claus Bogh Juhl, Sten Madsbad, Grethe Jakobsen, Kristine B. Degn, B. Nyholm, Oluf Pedersen, Jørgen Rungby, Niels Pörksen and Joergen Rungby and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Ole Schmitz

55 papers receiving 3.5k citations

Peers

Ole Schmitz
Ole Schmitz
Citations per year, relative to Ole Schmitz Ole Schmitz (= 1×) peers Richard D. Carr

Countries citing papers authored by Ole Schmitz

Since Specialization
Citations

This map shows the geographic impact of Ole Schmitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Schmitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Schmitz more than expected).

Fields of papers citing papers by Ole Schmitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Schmitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Schmitz. The network helps show where Ole Schmitz may publish in the future.

Co-authorship network of co-authors of Ole Schmitz

This figure shows the co-authorship network connecting the top 25 collaborators of Ole Schmitz. A scholar is included among the top collaborators of Ole Schmitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole Schmitz. Ole Schmitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Magnusson, Nils E., Steen Buus Kristiansen, Niels Jessen, et al.. (2011). Microarray expression analysis in delayed cardioprotection: the effect of exercise, AICAR, or metformin and the possible role of AMP-activated protein kinase (AMPK). Molecular and Cellular Biochemistry. 360(1-2). 353–362. 16 indexed citations
2.
Grønbæk, Henning, Karen Louise Thomsen, Jørgen Rungby, Ole Schmitz, & Hendrik Vilstrup. (2008). Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes. Expert Review of Gastroenterology & Hepatology. 2(5). 705–711. 35 indexed citations
3.
Rungby, Joergen, et al.. (2008). No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon‐like‐peptide‐1 administration in fasting healthy subjects. Clinical Endocrinology. 71(4). 500–506. 24 indexed citations
4.
Schmitz, Ole, Birgitte Brock, Jørgen Rungby, & Sten Madsbad. (2006). [The place of Glitazones in the treatment of diabetes: after the PROactive study].. PubMed. 168(18). 1750–2.
5.
Østergård, Torben, Jesper L. Andersen, B. Nyholm, et al.. (2005). Impact of exercise training on insulin sensitivity, physical fitness, and muscle oxidative capacity in first-degree relatives of type 2 diabetic patients. American Journal of Physiology-Endocrinology and Metabolism. 290(5). E998–E1005. 69 indexed citations
6.
Gromada, Jesper, Birgitte Brock, Ole Schmitz, & Patrik Rorsman. (2004). Glucagon‐Like Peptide‐1: Regulation of Insulin Secretion and Therapeutic Potential. Basic & Clinical Pharmacology & Toxicology. 95(6). 252–262. 78 indexed citations
7.
Jessen, Niels, Christian Djurhuus, Jens Otto Lunde Jørgensen, et al.. (2004). Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion. American Journal of Physiology-Endocrinology and Metabolism. 288(1). E194–E199. 56 indexed citations
8.
Mari, Andrea, Amalia Gastaldelli, Andrea Natali, et al.. (2004). Characterization of β-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests. American Journal of Physiology-Endocrinology and Metabolism. 288(3). E541–E546. 22 indexed citations
9.
Degn, Kristine B., Birgitte Brock, Claus Bogh Juhl, et al.. (2004). Effect of Intravenous Infusion of Exenatide (Synthetic Exendin-4) on Glucose-Dependent Insulin Secretion and Counterregulation During Hypoglycemia. Diabetes. 53(9). 2397–2403. 216 indexed citations
10.
Rasmussen, Birthe M., L. Ørskov, Ole Schmitz, & Kjeld Hermansen. (2001). Alcohol and glucose counterregulation during acute insulin-induced hypoglycemia in type 2 diabetic subjects. Metabolism. 50(4). 451–457. 12 indexed citations
11.
Bøtker, Hans Erik, et al.. (1998). Effects of doxazosin on exercise-induced angina pectoris, ST-segment depression, and insulin sensitivity in patients with syndrome X. The American Journal of Cardiology. 82(11). 1352–1356. 28 indexed citations
12.
Pörksen, Niels, Thorbjørn Grøfte, B. Nyholm, et al.. (1998). Glucagon-Like Peptide 1 Increases Mass But Not Frequency or Orderliness of Pulsatile Insulin Secretion. Diabetes. 47(1). 45–49. 31 indexed citations
13.
Bøtker, Hans Erik, Christian Skjærbæk, Ulrik Eriksen, Ole Schmitz, & Hans Ørskov. (1997). Insulin-Like Growth Factor-I, Insulin, and Angina Pectoris Secondary to Coronary Atherosclerosis, Vasospasm, and Syndrome X. The American Journal of Cardiology. 79(7). 961–963. 27 indexed citations
14.
Hussain, Mehboob A., Ole Schmitz, Jens Sandahl Christiansen, Jürgen Zapf, & E. R. Froesch. (1995). Metabolic effects of insulin-like growth factor-I: A focus on insulin sensitivity. Metabolism. 44(10 Suppl 4). 108–112. 12 indexed citations
15.
Jørgensen, Jens Otto Lunde, Steen B. Pedersen, Jens Børglum, et al.. (1994). Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: A double-blind placebo-controlled study. Metabolism. 43(7). 872–877. 62 indexed citations
16.
Gøtzsche, Ole, Inger Sihm, Sten Lund, & Ole Schmitz. (1993). Abnormal changes in transmitral flow after acute exposure to nitroglycerin and nifedipine in uncomplicated insulin-dependent diabetes mellitus: A Doppler echocardiographic study. American Heart Journal. 126(6). 1417–1426. 6 indexed citations
17.
Hother‐Nielsen, Ole, Ole Schmitz, P. H. Andersen, Henning Beck‐Nielsen, & Oluf Pedersen. (1989). Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes. European Journal of Endocrinology. 120(3). 257–265. 101 indexed citations
18.
Schmitz, Ole. (1989). Effects of physiologic and supraphysiologic hyperglycemia on early and late-phase insulin secretion in chronically dialyzed uremic patients. European Journal of Endocrinology. 121(2). 251–258. 5 indexed citations
19.
Schmitz, Ole. (1988). Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. European Journal of Endocrinology. 118(1). 125–134. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026